Decision aid for patients with medullary thyroid cancer and their caregivers
Designing a Decision Aid to Help People With Medullary Thyroid Cancer Make Decisions With Their Doctors About Whether to Start or Stop New Drugs, Enroll in Clinical Trials, or Continue With Active Surveillance
This study is testing a new tool to help patients with medullary thyroid cancer and their caregivers make better choices about treatment and care options.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT03892993 on ClinicalTrials.gov |
What this trial studies
This trial focuses on developing and evaluating a patient decision aid designed to assist individuals with medullary thyroid cancer and their caregivers in making informed decisions regarding treatment options, clinical trial participation, and active surveillance. The study aims to assess the decision-making needs of patients, caregivers, and healthcare providers, and to create a prototype of the decision aid. Participants will use the decision aid and provide feedback through questionnaires to evaluate its acceptability and usability in real-world settings.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with medullary thyroid carcinoma and their caregivers.
Not a fit: Patients with cognitive or psychological impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this decision aid could empower patients and caregivers to make better-informed choices about cancer care.
How similar studies have performed: Other studies have shown success in using decision aids for cancer treatment decisions, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years old or older * Have or will face(d) this decision, including: Patient/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in the Genetics of Endocrine Neoplasia Registry or sporadic (medullary thyroid carcinoma) MTC database; Caregiver/family member - of patient/survivor who has medullary thyroid carcinoma, as nominated by the patient/survivor; and Provider - who treats patients/survivors who have medullary thyroid carcinoma, as described above * Able to speak, read, and write English * Pregnant patients are included Exclusion Criteria: --Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness; as documented in the registry)
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Elizabeth G Grubbs, MD — M.D. Anderson Cancer Center
- Study coordinator: Elizabeth G Grubbs, MD
- Email: eggrubbs@mdanderson.org
- Phone: (713) 792-0665
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.